(ENSG) The Ensign - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US29358P1012
ENSG: Nursing Homes, Rehabilitation Services, Senior Living Facilities, Pharmacy Services
The Ensign Group, Inc. (NASDAQ:ENSG) is a significant player in the healthcare services sector, focusing on skilled nursing, senior living, and rehabilitative care. This company is structured into two main segments: Skilled Services and Standard Bearer, each catering to different aspects of healthcare delivery.
The Skilled Services segment is the operational backbone, managing skilled nursing facilities and rehabilitation therapy services. These services are crucial for patients needing prolonged care, whether due to chronic conditions or age-related health issues. Beyond the basics, they offer specialized care such as on-site dialysis and ventilator care, which are essential for patients with severe medical needs. Additionally, they provide standard services that enhance patient comfort and well-being, including nutritional programs and social activities.
The Standard Bearer segment adds a strategic real estate dimension to their operations. By owning and leasing properties to healthcare operators, they create a steady revenue stream that supports their core healthcare services. This segment not only diversifies their income but also underscores their commitment to maintaining high-quality facilities.
Ensign Groups service portfolio extends beyond facilities to include ancillary services like mobile diagnostics and patient transportation. These offerings ensure comprehensive care, whether patients are at home or in a facility. Their operational footprint spans multiple states, indicating a strategic presence in key markets.
From an investment perspective, Ensign Group presents an interesting case. Their dual focus on healthcare and real estate provides a balanced risk profile. The real estate segment offers stable cash flows, while the healthcare services tap into the growing demand for post-acute care. Investors should consider their operational efficiency and ability to scale, which are crucial in the healthcare industry.
Financially, the company has a market cap of over $7.8 billion, with a P/E ratio indicating a premium valuation. Their price-to-book ratio suggests strong asset utilization, which is favorable for investors seeking growth. The diversification across services and real estate positions Ensign Group as a resilient player in the healthcare sector.
For those evaluating investment opportunities in healthcare, Ensign Groups model offers insights into how integrated services and strategic asset management can drive value. Their approach to patient care and operational efficiency makes them a company worth considering for those looking at the intersection of healthcare and real estate.
Additional Sources for ENSG Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ENSG Stock Overview
Market Cap in USD | 7,358m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 2007-11-09 |
ENSG Stock Ratings
Growth 5y | 82.9% |
Fundamental | 61.8% |
Dividend | 51.3% |
Rel. Strength Industry | 0.68 |
Analysts | 4.5/5 |
Fair Price Momentum | 122.65 USD |
Fair Price DCF | 66.68 USD |
ENSG Dividends
Dividend Yield 12m | 0.19% |
Yield on Cost 5y | 0.50% |
Annual Growth 5y | 3.68% |
Payout Consistency | 97.7% |
ENSG Growth Ratios
Growth Correlation 3m | -66.4% |
Growth Correlation 12m | 61.4% |
Growth Correlation 5y | 92.4% |
CAGR 5y | 21.25% |
CAGR/Max DD 5y | 0.44 |
Sharpe Ratio 12m | 0.03 |
Alpha | -6.67 |
Beta | 0.30 |
Volatility | 23.40% |
Current Volume | 343k |
Average Volume 20d | 491.4k |
As of February 22, 2025, the stock is trading at USD 126.34 with a total of 342,975 shares traded.
Over the past week, the price has changed by -1.30%, over one month by -9.32%, over three months by -14.22% and over the past year by +2.97%.
Yes, based on ValueRay Fundamental Analyses, The Ensign (NASDAQ:ENSG) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 61.82 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENSG as of February 2025 is 122.65. This means that ENSG is currently overvalued and has a potential downside of -2.92%.
The Ensign has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy ENSG.
- Strong Buy: 4
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, ENSG The Ensign will be worth about 137.2 in February 2026. The stock is currently trading at 126.34. This means that the stock has a potential upside of +8.56%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 166 | 31.4% |
Analysts Target Price | 169.5 | 34.2% |
ValueRay Target Price | 137.2 | 8.6% |